Voyager Therapeutics, Inc.

VYGR

NASDAQ

Healthcare

Biotechnology

Lexington, MA, US172 employeesvoyagertherapeutics.com

$3.94

-0.04(-1.13%)

Mkt Cap $235M

$2.73

$5.33

52-Week Range

At a Glance

AI-generated

Voyager Therapeutics, Inc.

Revenue breakdown: Single Reportable Segment (100%).

8-K

Voyager Therapeutics, Inc. filed an 8-K on March 9, 2026, under Item 2.02 with Exhibit 99.1 furnished, indicating results of operations or earnings disclosure. Item 2.02 and Exhibit 99.1 are not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.

$235M

Market Cap

$41M

Revenue

-$122M

Net Income

Employees172

Fundamentals

How The Business Makes Money

Revenue by Segment

Single Reportable Segment100%($370M)

Activity

What Changed Recently

Management Change

Feb 11, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation o

Financial Results

Mar 8, 2026

of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am

Regulation FD

Jan 7, 2026

of this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 hereto, the Company is not making an admission as to the materiality of any informat

Peer Companies

Company	Price	Change	Market Cap	P/E
ALLOAllogene Therapeutics, In...	$2.50	-2.54%	$608M	-2.8
TRDAEntrada Therapeutics, Inc...	$13.15	-2.45%	$503M	-3.3
AVIRAtea Pharmaceuticals, Inc...	$5.75	+1.86%	$459M	-2.7
VNDAVanda Pharmaceuticals Inc...	$6.99	-1.20%	$413M	-1.9
ENTAEnanta Pharmaceuticals, I...	$13.15	+1.39%	$305M	-3.8
ARCTArcturus Therapeutics Hol...	$8.00	+1.90%	$227M	-2.9
ACHVAchieve Life Sciences, In...	$3.23	+2.93%	$172M	-2.7
SGMTSagimet Biosciences Inc.	$5.30	+1.24%	$170M	-3.1

Analyst View

Company Profile

CIK0001640266

ISINUS92915B1061

CUSIP92915B106

Phone857 259 5340

Address75 Sidney Street, Lexington, MA, 02139, US

SEC EDGAR